Back to Search Start Over

The Appropriate Treatment of Chronic Pain

Authors :
Stefano Maria Zuccaro
Roberto Labianca
Piercarlo Sarzi-Puttini
Renato Vellucci
Diego Fornasari
Paolo Cherubino
Source :
Clinical Drug Investigation. 32:21-33
Publication Year :
2012
Publisher :
Springer Science and Business Media LLC, 2012.

Abstract

Chronic pain is a common healthcare problem worldwide that ranks as a predominant reason for consulting a physician, yet effective management of chronic pain remains suboptimal, often resulting in unnecessary suffering and decreased quality of life, lost productivity and excessive healthcare costs. To overcome the challenges associated with the management of chronic pain, increased awareness and both patient and physician education are required. Improving physician knowledge of pain assessment and management guided by recommendations for a comprehensive, multifactorial, personalised treatment approach involving pharmacological and non-pharmacological approaches is key to achieving effective pain relief. Guidelines for the management of non-cancer and cancer pain recommend thorough patient assessment before individualized therapy based on the type and intensity of pain. The availability of mechanism-specific analgesics has facilitated improvements in the treatment of chronic non-cancer pain, which may be of neuropathic, muscle, inflammatory, mechanical/compressive or mixed origin. Stepwise escalation of analgesic therapy (paracetamol, non-steroidal anti-inflammatory drugs, mild to strong opioids) according to the World Health Organization's three-step pain ladder remains the standard approach for the selection of treatment for chronic cancer pain, although there is now a greater awareness of the requirements for effective administration of opioids including dose titration, use of short versus long-acting opioids, opioid rotation, management of adverse effects, and ongoing monitoring. Selection of an effective, appropriate, personalized analgesic regimen for patients with chronic pain is achievable and is expected to enhance compliance, overall functioning and quality of life.

Details

ISSN :
11732563
Volume :
32
Database :
OpenAIRE
Journal :
Clinical Drug Investigation
Accession number :
edsair.doi.dedup.....9411273103bd67574aa31c0ec6b06835
Full Text :
https://doi.org/10.2165/11630050-000000000-00000